Gene · 55512
Papers1,535
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,535
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Dose C6 Ceramide-Induced Response in Embryonic Hippocampal Cells. | Biomolecules | 2025 | 40149966 | PubTator, text mining | PubMed |
| Blood Transcriptome Signature as Indicator and Predictor for Efficacy of Abrocitinib in Treatment of Atopic Dermatitis. | J Invest Dermatol | 2025 | 40058571 | PubTator, text mining | PubMed |
| Sphingomyelin phosphodiesterase 3 as a novel host factor inhibiting hepatitis B virus transcription. | Virol Sin | 2025 | 40023445 | PubTator, text mining | PubMed |
| Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism. | Cell Metab | 2025 | 40015281 | PubTator, text mining | PubMed |
| Quantitative proteomics identifies possible flow of metastatic cues between progressive stages of colorectal cancer via transfer of ceramide-dependent exosomal cargoes. | FEBS J | 2025 | 39948040 | PubTator, text mining | PubMed |
| Neutral sphingomyelinase 2: A promising drug target for CNS disease. | Adv Pharmacol | 2025 | 39929585 | PubTator, text mining | PubMed |
| The essential role of sphingolipids in TRPC5 ion channel localization and functionality within lipid rafts. | Pharmacol Res | 2025 | 39923924 | PubTator, text mining | PubMed |
| Genistein alleviates rheumatoid arthritis by inhibiting fibroblast-like synovial exosome secretion regulated by the Rab27/nSMase2/Mfge8 pathway. | Food Funct | 2025 | 39895262 | PubTator, text mining | PubMed |
| Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia. | Mol Psychiatry | 2025 | 39825014 | PubTator, text mining | PubMed |
| Role of Acorus calamus extract in reducing exosome secretion by targeting Rab27a and nSMase2: a therapeutic approach for breast cancer. | Mol Biol Rep | 2025 | 39812915 | PubTator, text mining | PubMed |
| Staying sane in the membrane: Neutral sphingomyelinase 2 as a master regulator of plasma membrane ceramide. | J Lipid Res | 2025 | 39732201 | PubTator, text mining | PubMed |
| Quinazoline derivatives as novel bacterial sphingomyelinase enzyme inhibitors. | Bioorg Chem | 2025 | 39729766 | PubTator, text mining | PubMed |
| Untargeted Spatial Metabolomics and Spatial Proteomics on the Same Tissue Section. | Anal Chem | 2025 | 39708340 | PubTator, text mining | PubMed |
| The steady-state level of plasma membrane ceramide is regulated by neutral sphingomyelinase 2. | J Lipid Res | 2025 | 39631562 | PubTator, text mining | PubMed |
| Electroacupuncture Ameliorates Knee Osteoarthritis By Rebalancing T Cell Homeostasis as Revealed By Immune Repertoire (IR) Sequencing. | Comb Chem High Throughput Screen | 2025 | 39136509 | PubTator, text mining | PubMed |
| Sedanolide alleviates DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice. | J Adv Res | 2025 | 38582300 | PubTator, text mining | PubMed |
| Matrix-associated extracellular vesicles modulate smooth muscle cell adhesion and directionality by presenting collagen VI. | bioRxiv | 2025 | 37645762 | PubTator, text mining | PubMed |
| The 3rd annual American Society for Intercellular Communication (ASIC) meeting, 2023 conference report. | Extracell Vesicles Circ Nucl Acids | 2024 | 39811728 | PubTator, text mining | PubMed |
| Blockade of neutral sphingomyelinase 2 exerts antitumor effect on metastatic castration resistant prostate cancer cells and promotes tumor regression when combined with Enzalutamide. | Am J Cancer Res | 2024 | 39803655 | PubTator, text mining | PubMed |
| The Role of Sphingolipid Metabolism in Pregnancy-Associated Breast Cancer After Chemotherapy. | Biomedicines | 2024 | 39767749 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55512/papers?page=4